Suraksha Diagnostic is a small-cap company that provides dozens of healthcare services, such as pathology and radiology. The company announced its IPO, which will open on 29 November 2024 and close on 3 December 2024. If you are also planning to apply or subscribe to the IPO, the Suraksha Diagnostic IPO GMP (grey market premium) today can help you to know its demand among investors.
The industry outlook is amazing, the Diagnostic market is likely to grow at 10-12% CAGR from FY2024-FY2028. Radiology is also expected to grow at the same rate in the next 4 years. The Suraksha Diagnostic also benefits from the growth in the market. It is, attracting a lot of long-term and short-term investors.
Suraksha Diagnostic IPO GMP Today
As of 03 Nov 2024, the Suraksha Diagnostic IPO GMP (grey market premium) Today is trading at Rs. 0. The current GMP, stock is expected to be listed in the NSE and BSE at Rs. 441.
| Date | Live IPO GMP | EST. Listing Gains | Price Band | IPO Size | Bidding Dates |
|---|---|---|---|---|---|
| 30 Nov, 2024 (Today) | ₹0 | ₹0% | ₹420 – ₹441 | ₹846.25Cr | 29 Nov – 3 Dec |
Disclaimer: AskDhan or we are not SEBI registered, and this is not a Buying or Selling recommendation. We will not be responsible for any loss or profit. This post is only for educational and learning purposes. All the targets given in the post are based on news, brokerage research, technical analysis, etc. We strongly recommend you talk to your financial advisor before making any decision.
About Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd was founded in 1992. It is a small-cap health services sector small-cap company. The company provides dozens of pathology and radiology services in various states of India.
With Suraksha Diagnostic Ltd, you can book a test and consult a doctor for any medical and service-related problems. Based on the uploaded tests, a doctor may recommend medicines for your medical problems. You can also book a test on their website.
The company provides services like Imaging, Neurology, Cardiology, Gastroenterology, and Pathology. It has 215 client touchpoints which included 49 diagnostic centers and 166 sample collection centers in various states of India.
As per annual profit and loss, Suraksha Diagnostic Ltd is a profitable company and making profits over the years. But, the profits of the company have not improved in the past few years, but are likely to improve as the market is going to grow a lot in the future.
Suraksha Diagnostic Ltd’s IPO Details
| IPO Type | Mainboard |
| IPO Open Date | 29 Nov 2024 |
| IPO Close Date | 3 Dec 2024 |
| IPO Listing Date | 6 Dec 2024 |
| IPO Refund Date | 5 Dec 2024 |
| IPO Allotment Date | 4 Dec 2024 |
| IPO Demat Credit Date | 5 Dec 2024 |
| IPO Price Band | ₹420 to ₹441 Per Share |
| IPO Listing | NSE & BSE |
| Issue Size | Approx ₹846.25 Crores |
| Fresh Issue | NA |
| Offer For Sale | Approx ₹1,91,89,330 Equity Shares |
| NII Quota | Not More Than 15% |
| QIB Quota | Not More Than 50% |
| Retail Quota | Not More Than 35% |
| Prospectus | Click Here |
Profit & Loss
Currently, there is no quarterly profit and loss data is publically available.
Annual Profit & Loss: 6 years of annual profit and loss data of the company is available publically i.e. March 2019, March 2020, March 2021, March 2022, March 2023, and March 2024. In all these years, the company has not made any loss as per annual profit and loss.
In March 2019 the company’s net profit was Rs. 19 Crore, In March 2020 Rs. 15 Crore net profit, In March 2021 Rs. 6 Crore profit, In March 2022 Rs. 24 Crore profit, In March 2023 Rs. 7 Crore profit, and in March 2024 Rs. 24 Crore net profit.
As you can see, over the years Suraksha Diagnostic Ltd’s profit has not improved well.
FAQs
The company is engaged in the health service business, it provides various services like pathology, radiology testing, and medical consultancy services.
In the categories, the company offers dozens of services.
It is a profitable company but the profits of the company’s net profit have not improved.
last 6 years’ company net annual profit & loss: In March 2019 the company’s net profit was Rs. 19 Crore, In March 2020 Rs. 15 Crore net profit, In March 2021 Rs. 6 Crore profit, In March 2022 Rs. 24 Crore profit, In March 2023 Rs. 7 Crore profit, and in March 2024 Rs. 24 Crore net profit.
The company generates maximum revenue from West Bengal, as per a recent report the company generated 95.34% (Q1 FY25) revenue from there.
As of 03 December 2024, the current GMP of the Suraksha Diagnostic IPO is trading at Rs. 0, which means as per the current GMP the IPO is likely to list in the NSE and BSE at Rs. 441 or 0% premium.
Final Words
Suraksha Diagnostic Ltd is a well-known company in the west Bengal, in a recent report the company generated 95.34% (Q1 FY2025) from the west Bengal. The company provides pathology services, radiology testing, and medical consultancy services to the people. As of now, the Suraksha IPO GMP (grey market premium) is trading at Rs. 0.